Goldstein, R. D., Kinney, H. C. & Willinger, M. Sudden unexpected death in fetal life through early childhood. Pediatrics 137, e20154661 (2016).
Moon, R. Y., Horne, R. S., & Hauck, F. R. Sudden infant death syndrome. Lancet 370, 1578–1587 (2007).
Kinney, H. C. & Thach, B. T. The sudden infant death syndrome. N. Engl. J. Med. 361, 795–805 (2009).
Goldstein, R. D., Trachtenberg, F. L., Sens, M. A., Harty, B. J. & Kinney, H. C. Overall postneonatal mortality and rates of SIDS. Pediatrics 137, e20152298 (2016).
Willinger, M. et al. Factors associated with the transition to nonprone sleep positions of infants in the United States: the national infant sleep position study. JAMA 280, 329–335 (1998).
Shapiro-Mendoza, C. K., Tomashek, K. M., Anderson, R. N. & Wingo, J. Recent national trends in sudden, unexpected infant deaths: more evidence supporting a change in classification or reporting. Am. J. Epidemiol. 163, 762–769 (2006).
Matthews, T. J., MacDorman, M. F. & Thoma, M. E. Infant mortality statistics from the 2013 period linked birth/infant death data set. Natl Vital Stat. Rep. 64, 1–30 (2015).
Guntheroth, W. G. & Spiers, P. S. The triple risk hypotheses in sudden infant death syndrome. Pediatrics 110, e64 (2002).
Filiano, J. J. & Kinney, H. C. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol. Neonate 65, 194–197 (1994).
Carlin, R. F. & Moon, R. Y. Risk factors, protective factors, and current recommendations to reduce sudden infant death syndrome: a review. JAMA Pediatr. 171, 175–180 (2017).
Weinberg, S. B. & Purdy, B. A. Postmortem leukocyte culture studies in sudden infant death. Nature 226, 1264–1265 (1970).
Froggatt, P., Lynas, M. A. & MacKenzie, G. Epidemiology of sudden unexpected death in infants ('cot death') in Northern Ireland. Br. J. Prev. Soc. Med. 25, 119–134 (1971).
Carpenter, R. G. et al. Repeat sudden unexpected and unexplained infant deaths: natural or unnatural? Lancet 365, 29–35 (2005).
Smialek, J. E. Simultaneous sudden infant death syndrome in twins. Pediatrics 77, 816–821 (1986).
Getahun, D., Demissie, K., Lu, S.-E. & Rhoads, G. G. Sudden infant death syndrome among twin births: United States, 1995–1998. J. Perinatol. 24, 544–551 (2004).
Van Norstrand, D. W & Ackerman, M. J. Genomic risk factors in sudden infant death syndrome. Genome Med. 2, 86 (2010).
Schwartz, P. J. Cardiac sympathetic innervation and the sudden infant death syndrome. A possible pathogenetic link. Am. J. Med. 60, 167–172 (1976).
Schwartz, P. J. et al. The QT interval throughout the first 6 months of life: a prospective study. Circulation 66, 496–501 (1982).
Schwartz, P. J. The quest for the mechanisms of the sudden infant death syndrome: doubts and progress. Circulation 75, 677–683 (1987).
Maron, B. J., Clark, C. E., Goldstein, R. E. & Epstein, S. E. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 54, 423–430 (1976).
Schwartz, P. J. et al. Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 338, 1709–1714 (1998).
Yiallourou, S. R., Sands, S. A., Walker, A. M. & Horne, R. S. C. Maturation of heart rate and blood pressure variability during sleep in term-born infants. Sleep 35, 177–186 (2012).
Jean-Louis, M. et al. Power spectral analysis of heart rate in relation to sleep position. Biol. Neonate 86, 81–84 (2004).
Schwartz, P. J. et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N. Engl. J. Med. 343, 262–267 (2000).
Schwartz, P. J. et al. Molecular diagnosis in a child with sudden infant death syndrome. Lancet 358, 1342–1343 (2001).
Wedekind, H. et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104, 1158–1164 (2001).
Ackerman, M. J. et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286, 2264–2269 (2001).
Priori, S. G. et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10, 1932–1963 (2013).
Brunklaus, A., Ellis, R., Reavey, E., Semsarian, C. & Zuberi, S. M. Genotype phenotype associations across the voltage-gated sodium channel family. J. Med. Genet. 51, 650–658 (2014).
Gray, B. & Behr, E. R. New insights into the genetic basis of inherited arrhythmia syndromes. Circ. Cardiovasc. Genet. 9, 569–577 (2016).
Schwartz, P. J. et al. Prevalence of the congenital long-QT syndrome. Circulation 120, 1761–1767 (2009).
Goldenberg, I. et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 117, 2184–2191 (2008).
Priori, S. G. et al. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348, 1866–1874 (2003).
Antzelevitch, C. et al. J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm 13, e295–e324 (2016).
Priori, S. G., Napolitano, C., Giordano, U., Collisani, G. & Memmi, M. Brugada syndrome and sudden cardiac death in children. Lancet 355, 808–809 (2000).
Andorin, A. et al. Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. Heart Rhythm 13, 1274–1282 (2016).
Tester, D. J. et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm 4, 733–739 (2007).
Neubauer, J. et al. Post-mortem whole-exome analysis in a large sudden infant death syndrome cohort with a focus on cardiovascular and metabolic genetic diseases. Eur. J. Hum. Genet. 25, 404–409 (2017).
Brugada, R. et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 30–35 (2004).
Arnestad, M. et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 115, 361–367 (2007).
Wang, D. W. et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115, 368–376 (2007).
Cronk, L. B. et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 4, 161–166 (2007).
Van Norstrand, D. W. et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116, 2253–2259 (2007).
Tan, B.-H. et al. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm 7, 771–778 (2010).
Cheng, J. et al. Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current. Circ. Arrhythm. Electrophysiol. 2, 667–676 (2009).
Hu, D. et al. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. Heart Rhythm 9, 760–769 (2012).
Behr, E. R. et al. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study. Cardiovasc. Res. 106, 520–529 (2015).
Tester, D. J. & Ackerman, M. J. Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc. Res. 67, 388–396 (2005).
Tester, D. J. et al. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ. Cardiovasc. Genet. 4, 510–515 (2011).
Giudicessi, J. R. et al. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum. Mutat. 33, 989–997 (2012).
Hertz, C. L. et al. Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases. Eur. J. Hum. Genet. 24, 817–822 (2016).
Crotti, L. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 127, 1009–1017 (2013).
Van Norstrand, D. W. et al. Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation 125, 474–481 (2012).
Evans, A., Bagnall, R. D., Duflou, J. & Semsarian, C. Postmortem review and genetic analysis in sudden infant death syndrome: an 11-year review. Hum. Pathol. 44, 1730–1736 (2013).
Plant, L. D. et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J. Clin. Invest. 116, 430–435 (2006).
Brion, M. et al. Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci. Int. 219, 278–281 (2012).
Wedekind, H. et al. Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study. Int. J. Legal Med. 120, 129–137 (2006).
Otagiri, T. et al. Cardiac ion channel gene mutations in sudden infant death syndrome. Pediatr. Res. 64, 482–487 (2008).
Millat, G. et al. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr. Cardiol. 30, 502–509 (2009).
Winkel, B. G. et al. The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome. Heart Rhythm 12, 1241–1249 (2015).
Anderson, J. H., Tester, D. J., Will, M. L. & Ackerman, M. J. Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young. Circ. Cardiovasc. Genet. 9, 259–265 (2016).
Ackerman, M. J. Genetic purgatory and the cardiac channelopathies: exposing the variants of uncertain/unknown significance issue. Heart Rhythm 12, 2325–2331 (2015).
Ackerman, M. J. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 8, 1308–1339 (2011).
Wong, L. C. H. & Behr, E. R. Sudden unexplained death in infants and children: the role of undiagnosed inherited cardiac conditions. Europace 16, 1706–1713 (2014).
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Probst, V. et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115, 2042–2048 (2007).
Skinner, J. R. et al. Brugada syndrome masquerading as febrile seizures. Pediatrics 119, e1206–e1211 (2007).
Behr, E. R. & Roden, D. Drug-induced arrhythmia: pharmacogenomic prescribing? Eur. Heart J. 34, 89–95 (2013).
Skinner, J. R. & Van Hare, G. F. Routine ECG screening in infancy and early childhood should not be performed. Heart Rhythm 11, 2322–2327 (2014).
Saul, J. P., Schwartz, P. J., Ackerman, M. J. & Triedman, J. K. Rationale and objectives for ECG screening in infancy. Heart Rhythm 11, 2316–2321 (2014).
Saul, J. P., Schwartz, P. J., Ackerman, M. J. & Triedman, J. K. Neonatal ECG screening: opinions and facts. Heart Rhythm 12, 610–611 (2015).
Schwartz, P. J. & Dagradi, F. Management of survivors of cardiac arrest — the importance of genetic investigation. Nat. Rev. Cardiol. 13, 560–566 (2016).
Petrikin, J. E., Willig, L. K., Smith, L. D. & Kingsmore, S. F. Rapid whole genome sequencing and precision neonatology. Semin. Perinatol. 39, 623–631 (2015).
Christiansen, M. et al. Mutations in the HERG K+-ion channel: a novel link between long QT syndrome and sudden infant death syndrome. Am. J. Cardiol. 95, 433–434 (2005).
Nof, E. et al. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ. Cardiovasc. Genet. 3, 199–206 (2010).
Kato, K. et al. Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench. J. Cardiovasc. Electrophysiol. 25, 66–73 (2014).
Sauer, C. W. & Marc-Aurele, K. L. A. Neonate with susceptibility to long QT syndrome type 6 who presented with ventricular fibrillation and sudden unexpected infant death. Am. J. Case Rep. 17, 544–548 (2016).
Yang, Y. et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am. J. Hum. Genet. 86, 872–880 (2010).
Skinner, J. R. et al. Near-miss SIDS due to Brugada syndrome. Arch. Dis. Child. 90, 528–529 (2005).
Turillazzi, E. et al. Heterozygous nonsense SCN5A mutation W822X explains a simultaneous sudden infant death syndrome. Virchows Arch. 453, 209–216 (2008).
Huang, H. et al. Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome. FEBS Lett. 583, 890–896 (2009).
Wang, D. W. et al. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ. Arrhythm. Electrophysiol. 1, 370–378 (2008).
Bankston, J. R. et al. A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response. PLoS ONE 2, e1258 (2007).